OpenResearchAlpha

Medicine · 20 Nov 2026

Risk of major adverse cardiovascular events and all-cause mortality across chronic kidney disease stages: A population-based retrospective cohort study in South Korea

Yookyung Leeh-index 8, Doo Woong Lee, Ye Seol Lee, Sung Hoon Jeong, Miji Kim, Hyunmi Oh, Soo Jin Kim, Hyang-Lim Lee, Ja-Ho Leighh-index 16

0
Citations
no database records one yet
0
Citations in 2026
so far
16
Leading author's h-index
Ja-Ho Leigh, in QAI's scholar index
18
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Chronic kidney disease (CKD) is associated with increased cardiovascular and all-cause mortality risk. However, few studies have assessed whether these risks vary across CKD stages in Asian populations. Using Korean National Health Insurance data (2016–2020), we analyzed a cohort of 51,352 individuals newly diagnosed with CKD. We compared incidence rates of major adverse cardiovascular events (MACE) and all-cause mortality across CKD stages. Model 1 adjusted for age and sex; Model 2, the primary adjusted model, additionally adjusted for income and health insurance coverage type. All covariates were ascertained on or before cohort entry. During follow-up, 9708 participants (18.9%) experienced MACE and 7091 (13.8%) died. Compared with stage 1 CKD, stage 5 CKD with dialysis was associated with higher hazards of MACE (Model 2 hazard ratio = 4.67; 95% confidence interval = 4.24–5.13) and all-cause mortality (hazard ratio = 5.61; 95% confidence interval = 4.94–6.38). The corresponding incidence rates were 26,148 MACE cases and 16,441 deaths per 100,000 person-years. Advanced CKD stages were associated with higher hazards of MACE and all-cause mortality after adjustment for baseline demographic and socioeconomic characteristics. Residual confounding by clinical characteristics remains possible.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Ja-Ho Leigh has the highest h-index among the authors (16).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (9)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (18)

What it cites, from open citation data, with Crossref's record of each.